Ultragenyx's Gene Therapy Wins First FDA Approval for Rare Metabolic Disorder

Published Date: 22 Aug 2026

Ultragenyx Pharmaceutical said on Wednesday that its gene therapy became the first to ⁠receive the U.S. Food and Drug Administration's approval to treat a rare metabolic...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chromatin organization linked to p53 tumor suppression mechanism

2.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

3.

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

4.

New protein target discovered for childhood medulloblastomas

5.

CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot